Hyponatremia related to medical anticancer treatment

Supportive Care in Cancer

Volumn 4, Issue 5, 1996, Pages 341-350

  Berghmans, T ^a,b  

^a JULES BORDET INSTITUTE   (Belgium)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Chemotherapy; Hyponatremia; Renal salt wasting; Syndrome of inappropriate secretion of antidiuretic hormone

Indexed keywords

ANTINEOPLASTIC AGENT;

CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; HUMAN; HYPONATREMIA; NEOPLASM; PATHOPHYSIOLOGY; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS; HUMANS; HYPONATREMIA; NEOPLASMS;

EID: 0030228117     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01788840     Document Type: Review

References (81)

1. Antony A, Robinson WA, Roy C, Pelander W, Donohue R (1980) Inappropriate antidiuretic hormone secretion after high dose vinblastine. J Urol 123:783-784
2. Bartter FC, Schwartz WB (1967) The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 42:790-806
3. Bennett CL, Vogelzang NJ, Ratain MJ, Reich SD (1986) Hyponatremia and other toxic effects during a phase I trial of recombinant human gamma interferon and vinblastine. Cancer Treat Rep 70:1081-1084
4. Bissett D, Cornford EJ, Sokal M (1989) Hyponatraemia following cisplatin chemotherapy. Ann Oncol 28:823
5. Bressler RB, Huston DP (1985) Water intoxication following moderate-dose intravenous cyclophosphamide. Arch Intern Med 145:548-549
6. Burdman JA (1966) A note on the selective toxicity of vincristine sulfate on chick-embryo sensory ganglia in tissue culture. J Natl Cancer Inst 37:331
7. Callewart CC, Minchew JT, Kanim LE, Tsai YC, Salehmoghaddam S, Dawson EG, Delamarter RB (1994) Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion in adult spinal surgery. Spine 19:1674-1679
8. Cantwell BMJ, Idle M, Millward MJ, Hall G, Lind MJ (1990) Encephalopathy with hyponatremia and inappropriate arginine vasopressin secretion following an intravenous ifosfamide infusion. Ann Oncol 1:232
9. Courjault-Gautier F, Hoet D, Leroy D, Toutain HJ (1994) Dissimilar alterations of sodium-coupled uptake by platinum-coordination complexes in renal proximal tubular cells in primary culture. J Pharmacol Exp Ther 270:1097-1104
10. Courjault-Gautier F, Le Grimmelec C, Giocondi MC, Toutain HJ (1995) Modulation of sodium-coupled uptake and membrane fluidity by cisplatin in renal proximal tubular cells in primary culture and brush-border membrane vesicles. Kidney Int 47:1048-1056
11. Culine S, Ghosn M, Droz JP (1990) Inappropriate antidiuretic hormone secretion induced by ifosfamide. Eur J Cancer 26:922
12. Cutting HO (1971) Inappropriate secretion of antidiuretic hormone secondary to vincristine therapy. Am J Med 51:269-271
13. Decaux G, Unger J, Brimioulle S, Mockel J (1982) Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy. JAMA 247:471-474
14. Decaux G, Prospert F, Penninckx R, Namias B, Soupart A (1993) 5-year treatment of the chronic syndrome of inappropriate secretion of ADH with oral urea. Nephron 63:468-470
15. DeFronzo RA, Braine H, Colvin M, Davis PJ (1973) Water intoxication in man after cyclophosphamide therapy. Time course and relation to drug activation. Ann Intern Med 78:861-869
16. El Weshi A, Thieblemont C, Cottin V, Barbet N, Catimel G (1995) Cisplatin-induced hyponatremia and renal sodium wasting. Acta Oncol 34:264-265
17. Escuro RS, Adelstein DJ, Carter SG (1992) Syndrome of inappropriate secretion of antidiuretic hormone after infusional vincristine. Cleve Clin J Med 59:643-644
18. Farkkilä M, Iivanainen M, Roine R, Bergström L, Laaksonen R, Niemi ML, Cantell K (1984) Neurotoxic and other side effects of high-dose interferon in amyotrophic lateral sclerosis. Acta Neurol Scand 69:42-46
19. Fine RN, Clarke RR, Shore NA (1966) Hyponatremia and vincristine therapy. Syndrome possibly resulting from inappropriate antidiuretic hormone secretion. Am J Dis Child 112:256-259
20. Frahm H, Hulst M von (1988) Increased secretion of vasopressin and edema formation in high dosage methotrexate therapy. Z Ges Inn Med 43:411-414
21. Fraschini G, Recchia F, Holmes FA (1987) Syndrome of inappropriate antidiuretic hormone secretion associated with hepatic arterial infusion of vinblastine in three patients with breast cancer. Tumori 73:513-516
22. Fukabori T, Nakamura T, Kida T, Fujita Y, Goto T, Hiramori N, Fujii T, Iwasaki Y, Nakagawa M (1991) Syndrome of inappropriate antidiuretic hormone secretion following cisplatinum and vindesine administration in a patient with squamous cell carcinoma of the lung. Gan To Kagaku Ryoho 18:1213-1216
23. Giaccone G, Donadio M, Ferrati P, Ciuffreda L, Bagatella M, Gaddi M, Calciati A (1985) Disorders of serum electrolytes and renal function in patients treated with cis-platinum on an outpatient basis. Eur J Cancer Clin Oncol 21:433-437
24. Ginsberg SJ, Comis RL, Fitzpatrick AV (1977) Vinblastine and inappropriate ADH secretion (letter). N Engl J Med 296:941
25. Ginsberg SJ, Comis RL, Miller M (1982) The development of hyponatremia following combination chemotherapy for metastatic germ cell tumors. Med Pediatr Oncol 10:7-14
26. Gonzales-Vitale JC, Haves DM, Cvitkovic E, Sternberg SS (1977) The renal pathology in clinical trials of cis-platinum (II) diamminedichloride. Cancer 39:1362-1371
27. Greenbaum-Lefkoe B, Rosenstock JG, Belasco JB, Rohrbaugh TM, Meadows AT (1985) Syndrome of inappropriate antidiuretic hormone secretion. A complication of high-dose intravenous melphalan. Cancer 55:44-46
28. Gross J, Steinberg SM, Reilly JG, Bliss DP, Brenan J, Tram Le P, Simmons A, Phelps R, Mulshine JL, Ihde DC, Johnson BE (1993) Atrial natriuretic factor and arginine vasopressin production in tumor cell lines from patients with lung cancer and their relationship to serum sodium. Cancer Res 53:67-74
29. Hainsworth JD, Workman R, Greco FA (1983) Management of the syndrome of inappropriate antidiuretic hormone secretion in small cell lung cancer. Cancer 51:161-165
30. Harlow PJ, DeClerck YA, Shore NA, Ortega JA, Carranza A, Heuser E (1979) A fatal case of inappropriate ADH secretion induced by cyclophosphamide therapy. Cancer 44:896-898
31. Hutchison FN, Perez EA, Gandara DR. Lawrence HJ, Kaysen GA (1988) Renal salt wasting in patients treated with cisplatin. Ann Intern Med 108:21-25
32. Istre O, Skajaa K, Schjoensby AP, Forman A (1992) Changes in serum electrolytes after transcervical resection of endometrium and submucous fibroids with use of glycine 1.5% for uterine irrigation. Obstet Gynecol 80:218-222
33. Izquierdo R, Leinung M (1993) Hyponatraemia secondary to administration of ifosfamide. Eur J Cancer 29A:2072-2073
34. Kennedy PGE, Mitchell DM, Hoffbrand BI (1978) Severe hyponatremia in hospital inpatients. BMJ 2:1251-1253
35. Kim YK, Byun HS, Kim YH, Woo JS, Lee SH (1995) Effect of cisplatin on renal function in rabbits: mechanism of reduced glucose reabsorption. Toxicol Appl Pharmacol 130:19-26
36. Kurtzberg J, Dennis VW, Kinney TR (1984) Cisplatinum-induced renal salt wastins. Med Pediatr Oncol 12:150-154
37. Lammers PJ, White L, Ettinger LJ (1984) Cis-platinum-induced renal sodium wasting. Med Pediatr Oncol 12:343-346
38. Lee YK, Shin DM (1992) Renal salt wasting in patients treated with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small cell lung cancer. Korean J Intern Med 7:118-121
39. Lei KIK, Wickham NWR, Johnson PJ (1995) Severe hyponatremia due to syndrome of inappropriate secretion of antidiuretic hormone in a patient receiving interferon-alpha for chronic myeloid leukemia (letter). Am J Hematol 49:100
40. Levin L, Sealy R, Barron J (1982) Syndrome of inappropriate antidiuretic hormone secretion following cis-dichlorodiammineplatinum II in a patient with malignant thymoma. Cancer 50:2279-2282
41. Mariette X, Paule B, Bennet P, Clerc D, Bisson M, Massias P (1988) Cisplatin and hyponatremia (letter). Ann Intern Med 108:770-771
42. McCarron MO, Wright GD, Roberts SD (1995) Water intoxication after low dose cyclophosphamide. BMJ 311:292
43. Mead GM, Arnold AM, Green JA, Macbeth FR, Williams CJ, Whitehouse JM (1982) Epileptic seizures associated with cisplatin administration. Cancer Treat Rep 66:1719-1722
44. Meriwether WD (1971) Vincristine toxicity with hyponatremia and hypochloremia in an adult. Oncology 25:234-238
45. Moses AM, Miller M (1974) Drug-induced dilutional hvponatremia. N Engl J Med 291:234-1239
46. Murray JL, Cunningham JE, Brewer H, Mujoo K, Zukiwski AA, Podoloff DA, Kasi LP, Bhadkamkar V, Pritsche HA, Benjamin RS, Legha SS, Ater JL, Jaffe N, Itoh K, Ross MI, Bucana CD, Thompson L, Cheung L, Rosenblum MG (1994) Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors. J Clin Oncol 12:184-193
47. Musch W, Thimpont J, Vandervelde D, Verhaeverbeke I, Berghmans T, Decaux G (1995) Combined fractional excretion of sodium and urea belter predicts response to saline in hyponatremia than do usual clinical and biochemical parameters. Am J Med 99:348-355
48. Orbo A, Simonsen E (1992) Cisplatin-induced sodium and magnesium wastage. Eur J Cancer 28A:1294
49. Porter AT (1985) Syndrome of inappropriate antidiuretic hormone secretion during cis-dichlorodiammineplatinum therapy in a patient with an ovarian carcinoma. Gynecol Oncol 21:103-105
50. Pratt CB, Douglass EC, Kovnar EH, Heideman R, Kun L, Avery L, Kellie SJ (1993) A phase I study of ifosfamide given on alternate days to treat children with brain tumors. Cancer 71:3666-3669
51. Quesada JR, Talpaz M, Rios A, Kurzrock R, Gutterman JU (1986) Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol 4:234-243
52. Ravikumar TS, Grage TB (1983) The syndrome of inappropriate ADH secretion secondary to vinblastine-bleomycin therapy. J Surg Oncol 24:242-245
53. Ribeiro RC, Rill D, Roberson PK, Furman WL, Pratt CB, Brenner M, Crist WM, Pui CH (1993) Continuous infusion of interleukin-2 in children with refractory malignancies. Cancer 72:623-628
54. Ritch PS (1988) Cis-dichlorodiammineplatinum II-induced syndrome of inappropriate secretion of antidiuretic hormone. Cancer 61:448-450
55. Robertson GL, Bhoopalam N, Zelkowitz LJ (1973) Vincristine neurotoxicity and abnormal secretion of antidiuretic hormone. Arch Intern Med 132:717-720
56. Rufener C, Nordmann J, Rouiller C (1972) Effet de la vincristine sur l'hypophyse postérieure de rat in vitro. Neurochirurgie 18:137-141
57. Saleh MN, Khazaeli MB, Wheeler RH, Dropcho E, Liu T, Urist M, Miller DM, Lawson S, Dixon P, Russell CH, LoBuglio AF (1992) Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma. Cancer Res 52:4342-4347
58. Sandborn WJ, Gross JB Jr, Larson DE. Phillips JK, Lindor KD (1993) High volume postobstructive choleresis after transhepatic external biliary drainage resolves with conversion to internal drainage. J Clin Gastroenterol 17:42-45
59. Santana VM, Schell MJ, Williams R, Bowman LC, Thompson EI, Brenner MK, Mirro J Jr (1992) Escalating sequential high dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors. Bone Marrow Transplant 10:457-462
60. Slater LM, Wainer RA, Serpick AA (1969) Vincristine neurotoxicity with hyponatremia. Cancer 23:122-125
61. Sorensen JB, Andersen MK, Hansen HH (1995) Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. J Intern Med 238:97-110
62. Stuart MJ, Cuaso C, Miller M, Oski FA (1975) Syndrome of recurrent increased secretion of antidiuretic hormone following multiple doses of vincristine. Blood 45:315-320
63. Suskind RM, Brusilow SW, Zehr J (1972) Syndrome of inappropriate secretion of antidiuretic hormone produced by vincristine toxicity (with bioassay of ADH level). J Pediatr 81:90-92
64. Tak PP, Diamant Z (1993) Hyponatremia, hyperkaliemia and hypercalcemia after ileal conduit diversion. Scand J Urol Nephrol 27:271-274
65. Takacs FJ (1975) Fluid and electrolyte problems in patients with advanced carcinoma. Med Clin North Am 59:449-457
66. Tauzin-Fin P, Sanz L (1992) Le syndrome de résection transuréthrale de la prostate. Ann Fr Anesth Reanim 11:168-177
67. Tomita M, Suzuki H, Matsuoka Y, Sakurada N (1981) Increased renal kallikrein excretion in SIADH after vincristine therapy. Endocrinol Jpn 28:637-641
68. Tomiwa K, Mikawa H, Hazama F, Yazawa K, Hosoya R, Ohya T, Nishimura K (1983) Syndrome of inappropriate secretion of antidiuretic hormone caused by vincristine therapy: a case report of the neuropathology. J Neurol 229:267-272
69. Tscherning C, Rubie H, Chancholle A, Claeyssens S, Robert A, Fabre J, Bouissou F (1994) Recurrent renal salt wasting in a child treated with carbopiatin and etoposide. Cancer 73:1761-1763
70. Tweedy CR, Silverberg DA, Scott L (1992) Levamisole-induced syndrome of inappropriate antidiuretic hormone. N Engl J Med 326:1164
71. Tzortzatou F, Dacou-Voutetakis C, Haidas S, Papadellis F, Thomaidis TH (1979) Electrolyte abnormalities in lymphosarcoma after chemotherapy. Acta Paediatr Scand 68:621-623
72. Uy QL, Moen TH, Johns RH, Owens AH (1967) Vincristine neurotoxicity in rodents. Johns Hopkins Med J 121:349-360
73. Vassal G, Rubie H, Kalifa C, Hartmann O, Lemerle J (1987) Hyponatremia and renal sodium wasting in patients receiving cisplatinum. Pediatr Hematol Oncol 4:337-344
74. Vaswani SK, Sprague R (1993) Pseudohyponatremia in multiple myeloma. South Med J 86:251-252
75. Vernant JP, Mouchnino G, Brun B, Reyes F, Kuentz M, Rochant H, Dreyfus B (1978) Les hyponatrémies au cours des leucémies aiguës. Ann Med Interne (Paris) 129:137-140
76. Wakem CJ, Bennett JM (1975) Inappropriate ADH secretion associated with massive vincristine overdosage. Aust NZ J Med 5:266-269
77. Webberley MJ, Murray JA (1989) Life-threatening acute hyponatraemia induced by low dose cyclophosphamide and indomethacin. Postgrad Med J 65:950-952
78. Welborn J, Meyers FJ, O'Grady LF (1988) Renal salt wasting and carboplatinum (letter). Ann Intern Med 108:640
79. White MG, Fetner CD (1975) Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with lithium carbonate. N Engl J Med 292:390-392
80. Whittaker JA, Parry DH, Bunch C, Weatherall DJ (1973) Coma associated with vincristine therapy. BMJ 4:335-337
81. Zavagli G, Ricci G, Tataranni G, Mapelli G, Abbasciano V (1988) Life-threatening hyponatremia caused by vinblastine. Med Oncol Tumor Pharmacother 5:67-69